These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23078109)

  • 21. Mechanisms of solvent evaporation encapsulation processes: prediction of solvent evaporation rate.
    Wang J; Schwendeman SP
    J Pharm Sci; 1999 Oct; 88(10):1090-9. PubMed ID: 10514360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
    J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
    Han Y; Tian H; He P; Chen X; Jing X
    Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
    Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
    Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation.
    Yeo Y; Basaran OA; Park K
    J Control Release; 2003 Dec; 93(2):161-73. PubMed ID: 14636722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CO2-assisted high pressure homogenization: a solvent-free process for polymeric microspheres and drug-polymer composites.
    Kluge J; Mazzotti M
    Int J Pharm; 2012 Oct; 436(1-2):394-402. PubMed ID: 22750408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method.
    Lee ES; Kwon MJ; Lee H; Kim JJ
    Int J Pharm; 2007 Feb; 331(1):27-37. PubMed ID: 17027204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A one-step process in preparation of cationic nanoparticles with poly(lactide-co-glycolide)-containing polyethylenimine gives efficient gene delivery.
    Shau MD; Shih MF; Lin CC; Chuang IC; Hung WC; Hennink WE; Cherng JY
    Eur J Pharm Sci; 2012 Aug; 46(5):522-9. PubMed ID: 22522118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microencapsulation reactor scale-up by dimensional analysis.
    Maa YF; Hsu C
    J Microencapsul; 1996; 13(1):53-66. PubMed ID: 8903785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY; Körber M; López Esguerra V; Bodmeier R
    J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsphere preparation using the untoxic solvent glycofurol.
    Allhenn D; Lamprecht A
    Pharm Res; 2011 Mar; 28(3):563-71. PubMed ID: 21049282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters.
    Parikh RH; Parikh JR; Dubey RR; Soni HN; Kapadia KN
    AAPS PharmSciTech; 2003; 4(2):E13. PubMed ID: 12916895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel preparation method for PLGA microspheres using non-halogenated solvents.
    Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
    J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation.
    Pamujula S; Graves RA; Moiseyev R; Bostanian LA; Kishore V; Mandal TK
    J Pharm Pharmacol; 2008 Mar; 60(3):283-9. PubMed ID: 18284807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
    Cohen-Sela E; Chorny M; Koroukhov N; Danenberg HD; Golomb G
    J Control Release; 2009 Jan; 133(2):90-5. PubMed ID: 18848962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release.
    Buske J; König C; Bassarab S; Lamprecht A; Mühlau S; Wagner KG
    Eur J Pharm Biopharm; 2012 May; 81(1):57-63. PubMed ID: 22306701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A; Burgess DJ
    Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.